Crossmark

Prophylactic early low-dose hydrocortisone and survival without bronchopulmonary dysplasia among extremely preterm infants born at 22–27 weeks’ gestation

Crossref DOI link: https://doi.org/10.1038/s41372-024-01923-5

Published Online: 2024-03-08

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shah, Sanket D. https://orcid.org/0000-0002-1033-0156
Shukla, Samarth https://orcid.org/0000-0002-5034-400X
Nandula, P. Sireesha https://orcid.org/0009-0009-5717-4494
Vice, Shannon

Elgendy, Marwa https://orcid.org/0000-0002-2361-983X
Gautam, Shiva

Hudak, Mark L. https://orcid.org/0000-0001-9405-3522
Cortez, Josef https://orcid.org/0000-0003-2181-5930
License Information

Text and Data Mining valid from 2024-03-08

Version of Record valid from 2024-03-08
More Information

Article History

Received: 17 December 2023

Revised: 21 February 2024

Accepted: 27 February 2024

First Online: 8 March 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below